Javascript must be enabled to continue!
Sex differences in factors predicting post‐treatment opioid use
View through CrossRef
AbstractBackground and aimsSeveral reports have documented risk factors for opioid use following treatment discharge, yet few have assessed sex differences, and no study has assessed risk using contemporary machine learning approaches. The goal of the present paper was to inform treatments for opioid use disorder (OUD) by exploring individual factors for each sex that are most strongly associated with opioid use following treatment.DesignSecondary analysis of Global Appraisal of Individual Needs (GAIN) database with follow‐ups at 3, 6 and 12 months post‐OUD treatment discharge, exploring demographic, psychological and behavioral variables that predict post‐treatment opioid use.SettingOne hundred and thity‐seven treatment sites across the United States.ParticipantsAdolescents (26.9%), young adults (40.8%) and adults (32.3%) in treatment for OUD. The sample (n = 1,126) was 54.9% male, 66.1% white, 20% Hispanic, 9.8% multi‐race/ethnicity, 2.8% African American and 1.3% other.MeasurementPrimary outcome was latency to opioid use over 1 year following treatment admission.ResultsFor women, regularized Cox regression indicated that greater withdrawal symptoms [hazard ratio (HR) = 1.31], younger age (HR = 0.88), prior substance use disorder (SUD) treatment (HR = 1.11) and treatment resistance (HR = 1.11) presented the largest hazard for post‐treatment opioid use, while a random survival forest identified and ranked substance use problems [variable importance (VI) = 0.007], criminal justice involvement (VI = 0.006), younger age (VI = 0.005) and greater withdrawal symptoms (VI = 0.004) as the greatest risk factors. For men, Cox regression indicated greater conduct disorder symptoms (HR = 1.34), younger age (HR = 0.76) and multiple SUDs (HR = 1.27) were most strongly associated with post‐treatment opioid use, while a random survival forests ranked younger age (VI = 0.023), greater conduct disorder symptoms (VI = 0.010), having multiple substance use disorders (VI = 0.010) and criminal justice involvement (VI = 0.006) as the greatest risk factors.ConclusionRisk factors for relapse to opioid use following opioid use disorder treatment appear to be, for women, greater substance use problems and withdrawal symptoms and, for men, younger age and histories of conduct disorder and multiple substance use disorder.
Title: Sex differences in factors predicting post‐treatment opioid use
Description:
AbstractBackground and aimsSeveral reports have documented risk factors for opioid use following treatment discharge, yet few have assessed sex differences, and no study has assessed risk using contemporary machine learning approaches.
The goal of the present paper was to inform treatments for opioid use disorder (OUD) by exploring individual factors for each sex that are most strongly associated with opioid use following treatment.
DesignSecondary analysis of Global Appraisal of Individual Needs (GAIN) database with follow‐ups at 3, 6 and 12 months post‐OUD treatment discharge, exploring demographic, psychological and behavioral variables that predict post‐treatment opioid use.
SettingOne hundred and thity‐seven treatment sites across the United States.
ParticipantsAdolescents (26.
9%), young adults (40.
8%) and adults (32.
3%) in treatment for OUD.
The sample (n = 1,126) was 54.
9% male, 66.
1% white, 20% Hispanic, 9.
8% multi‐race/ethnicity, 2.
8% African American and 1.
3% other.
MeasurementPrimary outcome was latency to opioid use over 1 year following treatment admission.
ResultsFor women, regularized Cox regression indicated that greater withdrawal symptoms [hazard ratio (HR) = 1.
31], younger age (HR = 0.
88), prior substance use disorder (SUD) treatment (HR = 1.
11) and treatment resistance (HR = 1.
11) presented the largest hazard for post‐treatment opioid use, while a random survival forest identified and ranked substance use problems [variable importance (VI) = 0.
007], criminal justice involvement (VI = 0.
006), younger age (VI = 0.
005) and greater withdrawal symptoms (VI = 0.
004) as the greatest risk factors.
For men, Cox regression indicated greater conduct disorder symptoms (HR = 1.
34), younger age (HR = 0.
76) and multiple SUDs (HR = 1.
27) were most strongly associated with post‐treatment opioid use, while a random survival forests ranked younger age (VI = 0.
023), greater conduct disorder symptoms (VI = 0.
010), having multiple substance use disorders (VI = 0.
010) and criminal justice involvement (VI = 0.
006) as the greatest risk factors.
ConclusionRisk factors for relapse to opioid use following opioid use disorder treatment appear to be, for women, greater substance use problems and withdrawal symptoms and, for men, younger age and histories of conduct disorder and multiple substance use disorder.
Related Results
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED]Keanu Reeves CBD Gummies ==❱❱ Huge Discounts:[HURRY UP ] Absolute Keanu Reeves CBD Gummies (Available)Order Online Only!! ❰❰= https://www.facebook.com/Keanu-Reeves-CBD-G...
(
2R,6R
)-hydroxynorketamine facilitates extinction and prevents emotional impairment and stress-induced reinstatement in morphine abstinent mice
(
2R,6R
)-hydroxynorketamine facilitates extinction and prevents emotional impairment and stress-induced reinstatement in morphine abstinent mice
ABSTRACT
Opioid addiction is a pressing public health concern marked by frequent relapse during periods of abstinence, perpetuated by negative af...
Impact of continuous infusions of opioids on discharge opioid prescriptions
Impact of continuous infusions of opioids on discharge opioid prescriptions
Introduction: The 2018 Pain, Agitation/Sedation, Delirium, Immobility, and Sleep guidelines from the Society of Critical Care Medicine recommend opioids as a first-line treatment o...
Implementation of a Quality Improvement Initiative to Decrease Opioid Prescribing After Cesarean Delivery
Implementation of a Quality Improvement Initiative to Decrease Opioid Prescribing After Cesarean Delivery
OBJECTIVE:
To assess whether a multiphase, departmental quality improvement effort decreases opioid prescribing and increases multimodal analgesic use after cesarean de...
Exploring the impact of the opioid epidemic in Black and Hispanic communities in the United States
Exploring the impact of the opioid epidemic in Black and Hispanic communities in the United States
Context: In recent years, due to an alarming increase in the number of opioid-related overdose fatalities for White, Non-Hispanics in rural and suburban communities across the Unit...
Abstract 4360: Opioid, non-opioid, and non-pharmacological pain management in patients with a history of cancer
Abstract 4360: Opioid, non-opioid, and non-pharmacological pain management in patients with a history of cancer
Abstract
Background Pain is highly prevalent among individuals with cancer. Consequently, adequate and equitable pain management are hallmarks of quality cancer care...
Severity of opioid dependence and its relation with psychosocial factors of users.
Severity of opioid dependence and its relation with psychosocial factors of users.
Objectives: To determine the relationship between severe opioid dependence and psychosocial factors of users Study Design: Descriptive Cross Sectional study. Setting: Department of...
Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine
Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine
Abstract
Background: The management of pain in adults with sickle cell disease (SCD) is complex, with the intermingling of both acute vaso-occlusive events and chron...

